Ovarian cancer is less common than breast cancer but far deadlier per case, because it's usually found late. There's no reliable screening test — which makes knowing the subtle symptoms and your genetic risk the best defense.
The ovaries sit deep in the pelvis, so early tumors cause vague symptoms — bloating, feeling full quickly, pelvic pain — that are easy to attribute to everyday causes. By the time it's obvious, it has often spread.
There is no good screening test for average-risk women. So the two levers that matter most are recognizing persistent new symptoms and knowing your genetic risk (especially BRCA), which can justify risk-reducing surgery.
📊 Data sourcesACS Cancer Facts & FiguresNCI SEER Stat FactsOvarian cancer begins in the ovaries or nearby fallopian tubes and peritoneum. Most are epithelial tumors; high-grade serous is the most common and aggressive type. It tends to spread within the abdomen before causing clear symptoms.
Caught early it's very survivable (~93% at 5 years), but only about 1 in 5 cases are found that early. Persistent, new symptoms lasting more than a couple of weeks deserve evaluation — that awareness is currently our best early-detection tool.
Bloating, early fullness, pelvic pain, urinary urgency.
Inherited mutations are a major driver — genetic testing helps.
No reliable test for average-risk women.
~93% 5-year survival when caught early.
A risk factor raises the odds — it doesn't guarantee the disease. Many people with risk factors never develop ovarian cancer, and some with none do. The point is to know your risk so you can act on what's modifiable.
The strongest risk factors — testing can be life-saving.
Ovarian or breast cancer in close relatives.
Most cases occur after menopause.
Never having carried a pregnancy raises risk.
Associated with certain ovarian cancer types.
Long-term estrogen-only HRT may slightly raise risk.
For average-risk women, routine screening (CA-125, ultrasound) is not recommended — it doesn't reliably catch cancer early and leads to unnecessary surgery.
For high-risk women (BRCA, Lynch, strong family history), the approach is different: genetic counseling, close monitoring, and the option of risk-reducing removal of the tubes and ovaries once childbearing is complete — which dramatically lowers risk.
📊 Data sourcesACS Cancer Facts & FiguresUSPSTF Screening RecommendationsThere is no recommended screening test for average-risk women — so awareness and genetics carry the load. The symptoms are real but subtle; the key is persistence and change.
Some factors meaningfully lower ovarian cancer risk — particularly for women who know they carry genetic risk.
Knowing BRCA/Lynch status opens risk-reducing options.
Long-term use lowers risk substantially.
Both are associated with lower risk.
For high-risk women, removing tubes/ovaries cuts risk dramatically.
Linked to certain ovarian cancer types.
Early evaluation is the best non-genetic lever.
Sources: American Cancer Society, NCI SEER, USPSTF (against routine screening in average-risk women).
Ovarian cancer rarely shouts. Learn the persistent symptoms, and if ovarian or breast cancer runs in your family, ask about genetic testing — it can open prevention options that save lives.